Warby Parker Inc. (WRBY) 8-K Current Report: February 26, 2026
Filed: February 26, 2026
Health Care
Ophthalmic GoodsWarby Parker Inc. (WRBY) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 2.02: Results of Operations and Financial Condition
- Item 8.01: Other Events
Warby Parker Inc. 8-K Feb 26, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q1 2025 earnings press release filed as exhibit — refer to Exhibit 99.1 for full financial results and key metrics
- • Reg FD safe harbor language indicates results are disclosed but not incorporated by reference into other SEC filings
Item 8.01 · Other Events
- • Board authorized up to $100M share repurchase program for Class A common stock, announced Feb 26, 2026
- • No fixed expiration date and no minimum purchase obligation — program can be modified, suspended, or terminated at any time
- • Buybacks via open market, private transactions, or Rule 10b5-1 plans, subject to Rule 10b-18 pricing/volume limits
- • Signal of management confidence in valuation; reduces share count over time, potentially accretive to EPS if executed
Get deeper insights on Warby Parker Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.